Online Inquiry
AKT2 (-/-) Cell Line
SPL-00197
| Size | Price |
| 1 Unit | Online Inquiry |
| Description |
|---|
| AKT2 (-/-) |
| Target Information | |
|---|---|
| Target Name | Akt |
| Gene Abbr. | AKT2 |
| Gene ID | 208 |
| Full Name | AKT serine/threonine kinase 2 |
| Alias | HIHGHH, PKBB, PKBBETA, PRKBB, RAC-BETA |
| Species | Human |
| Genomic Locus | 19q13.1-q13.2 |
| Introduction | This gene is a putative oncogene encoding a protein belonging to a subfamily of serine/threonine kinases containing SH2-like (Src homology 2-like) domains. The gene was shown to be amplified and overexpressed in 2 of 8 ovarian carcinoma cell lines and 2 of 15 primary ovarian tumors. Overexpression contributes to the malignant phenotype of a subset of human ductal pancreatic cancers. The encoded protein is a general protein kinase capable of phophorylating several known proteins. [provided by RefSeq, Jul 2008]. |
| Product Details | |
|---|---|
| Cell Line Model | DLD-1 |
| Genotype | AKT2 (-/-) |
| Description | AKT2 (-/-) |
| Parental ATCC ID | CCL-221 |
| STR Profile | Amelogenin: X,Y; CSF1PO: 11,12; D13S317: 8,11; D16S539: 12,13; D5S818: 13; D7S820: 10,12; THO1: 7,9.3; TPOX: 8,11; vWA: 18,19; ATCC |
| Disease | Colorectal adenocarcinoma, Dukes Type C |
| Tissue | Colon |
| Gender | Male |
| Key Endogenous Mutations | APC, BRCA2, FAM123B, KRAS, MSH6, PI3KA, TP53, |
| CVT Selection Condition | G418 resistant - 0.4 mg/mL |
| Cell Number | 1x10^6 |
| Handling Specifications | |
|---|---|
| Revival | Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Cells should be passaged every 3-5 days. Split at 70-80% confluency, approximately 1:6-1:10. |
| Culture Medium | RPMI 1640 including 2 mM L-glutamine and 25 mM sodium bicarbonate, supplemented with 10% FBS. |
| Growth Properties | Cells are cultured as a monolayer at 37°C in a humidified atmosphere with 5% CO2. Cells should be passaged every 3-5 days. Split at 70-80% confluency, approximately 1:6-1:10. |
| Freeze Medium | Complete growth media 45% + USDA approved FBS 50% + DMSO 5% |
| Biosafety Level | BSL-1 |
| Disclaimer | This product is classified under IATA regulations as a GMMO (genetically modified micro-organism) and will ship as UN3245. If applicable, ensure facility meets all requirements per local and country regulations. |
For research use only. Not intended for any clinical use. No products from CD BioSciences may be resold, modified for resale or used to manufacture commercial products without prior written approval from CD BioSciences.